| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Pharming Group N.V (AS: PHARM)
PHARM Technical Analysis
4
| As on 14th Mar 2025 PHARM STOCK Price closed @ 0.79 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.95 & Strong Sell for SHORT-TERM with Stoploss of 1.07 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PHARMSTOCK Price
| Open | 0.84 | Change | Price | % |
| High | 0.85 | 1 Day | -0.05 | -5.95 |
| Low | 0.77 | 1 Week | -0.02 | -2.47 |
| Close | 0.79 | 1 Month | -0.08 | -9.20 |
| Volume | 17277696 | 1 Year | -0.33 | -29.46 |
| 52 Week High 1.20 | 52 Week Low 0.65 | ||||
AS Netherlands Most Active Stocks
| RDSA | 22.80 | -1.08% |
| PHARM | 0.79 | -5.95% |
| INGA | 18.54 | 1.31% |
| KPN | 3.75 | -0.79% |
| AGN | 5.88 | 1.38% |
| UMG | 25.46 | -8.75% |
| ABN | 19.63 | 3.32% |
| MT | 29.61 | 3.57% |
| PRX | 43.47 | 1.83% |
| AD | 33.73 | -0.68% |
AS Netherlands Top Gainers Stocks
AS Netherlands Top Losers Stocks
| PHARM Daily Charts |
PHARM Intraday Charts |
Whats New @ Bazaartrend |
PHARM Free Analysis |
|
|
PHARM Important Levels Intraday
| RESISTANCE | 0.94 |
| RESISTANCE | 0.89 |
| RESISTANCE | 0.86 |
| RESISTANCE | 0.83 |
| SUPPORT | 0.75 |
| SUPPORT | 0.72 |
| SUPPORT | 0.69 |
| SUPPORT | 0.64 |
PHARM Forecast March 2025
| 4th UP Forecast | 1.12 |
| 3rd UP Forecast | 1.01 |
| 2nd UP Forecast | 0.95 |
| 1st UP Forecast | 0.88 |
| 1st DOWN Forecast | 0.7 |
| 2nd DOWN Forecast | 0.63 |
| 3rd DOWN Forecast | 0.57 |
| 4th DOWN Forecast | 0.46 |
PHARM Weekly Forecast
| 4th UP Forecast | 0.98 |
| 3rd UP Forecast | 0.92 |
| 2nd UP Forecast | 0.88 |
| 1st UP Forecast | 0.84 |
| 1st DOWN Forecast | 0.74 |
| 2nd DOWN Forecast | 0.70 |
| 3rd DOWN Forecast | 0.66 |
| 4th DOWN Forecast | 0.60 |
PHARM Forecast2025
| 4th UP Forecast | 1.89 |
| 3rd UP Forecast | 1.54 |
| 2nd UP Forecast | 1.32 |
| 1st UP Forecast | 1.1 |
| 1st DOWN Forecast | 0.48 |
| 2nd DOWN Forecast | 0.26 |
| 3rd DOWN Forecast | 0.04 |
| 4th DOWN Forecast | -0.31 |
Pharming Group N.V ( AS Netherlands Symbol : PHARM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PHARM Business Profile
Pharming Group N.V., a specialty pharmaceutical company, develops products for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment of pre- eclampsia, acute kidney injury, and COVID-19; leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) to treat patients with activated activated PI3K delta syndrome; and alpha-glucosidase therapy for the treatment of pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105, an investigational ex vivo autologous hematopoietic stem cell gene therapy for the treatment of hereditary angioedema. Pharming Group N.V. is headquartered in Leiden, the Netherlands. Address: Darwinweg 24, Leiden, Netherlands, 2333 CR
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service